Aspen Notre Dame de Bondeville, Notre Dame de Bondeville, France – FDA Inspections

Inspection records and compliance data for Aspen Notre Dame de Bondeville in Notre Dame de Bondeville. 8 FDA inspections on record, last inspected November 07, 2025.

Company Profile

This profile covers Aspen Notre Dame de Bondeville based in Notre Dame de Bondeville, France.

FDA Inspection History

FDA inspections: 8
OAI: 0
VAI: 3
NAI: 3
Unclassified: 2
Form 483s: 0
Warning letters: 0

First inspected March 17, 2009. Last inspected November 7, 2025.

FDA inspections (8)

Date	Result	FDA center(s)	Insp. #
November 7, 2025	Not classified	Human Drugs	1309944
June 7, 2024	Not classified	Biologics	1245201
April 16, 2021	VAI	Human Drugs · Drug Quality Assurance	1174998
May 31, 2018	NAI	Human Drugs · Drug Quality Assurance	1058932
August 30, 2016	NAI	Human Drugs · Drug Quality Assurance	988923
September 17, 2013	NAI	Human Drugs · Drug Quality Assurance	850923
September 2, 2011	VAI	Human Drugs · Drug Quality Assurance	749604
March 17, 2009	VAI	Human Drugs · Drug Quality Assurance	577591

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Organon Heist

Fresenius Kabi iPSUM Srl

Zhejiang Yongning Pharmaceutical Co., Ltd.

Baxter Healthcare S.A.

Baxter, S.A. De C.V.

BAYER PHARMA, AG

N.V. Organon (MSD)

Hainan Shuangcheng Pharmaceuticals Co Ltd

ONY Biotech, Inc.

GlaxoSmithKline, LLC.